Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT04432831




Registration number
NCT04432831
Ethics application status
Date submitted
12/06/2020
Date registered
16/06/2020
Date last updated
14/02/2024

Titles & IDs
Public title
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
Scientific title
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Patients With Diabetic Macular Edema
Secondary ID [1] 0 0
2020-000402-29
Secondary ID [2] 0 0
GR41987
Universal Trial Number (UTN)
Trial acronym
Rhone-X
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Diabetic Macular Edema 0 0
Condition category
Condition code
Eye 0 0 0 0
Diseases / disorders of the eye
Cardiovascular 0 0 0 0
Diseases of the vasculature and circulation including the lymphatic system

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - Faricimab
Other interventions - Sham Procedure

Experimental: Faricimab PTI -


Treatment: Drugs: Faricimab
Faricimab will be administered by intravitreal (IVT) injection into the study eye according to the personalized treatment interval (PTI) dosing regimen.

Other interventions: Sham Procedure
The sham is a procedure that mimics an IVT injection and involves the blunt end of an empty syringe (without a needle) being pressed against the anesthetized eye. The sham procedure will be administered to participants as appropriate during the first 16 weeks of this study in order to maintain the masking of the initial faricimab PTI.
Intervention code [1] 0 0
Treatment: Drugs
Intervention code [2] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Incidence and Severity of Ocular Adverse Events
Timepoint [1] 0 0
Up to 2 years
Primary outcome [2] 0 0
Incidence and Severity of Systemic (Non-Ocular) Adverse Events
Timepoint [2] 0 0
Up to 2 years
Primary outcome [3] 0 0
Number of Participants with Presence of Anti-Drug Antibodies (ADAs) at Baseline and Incidence of ADAs During the Study
Timepoint [3] 0 0
From Baseline up to 2 years

Eligibility
Key inclusion criteria
- Previous enrollment in and completion of Study GR40349 (NCT03622580) or GR40398
(NCT03622593), without study or study drug discontinuation

- Ability to comply with the study protocol, in the investigator's judgment

- For women of childbearing potential: agreement to remain abstinent or use acceptable
contraceptive methods that result in a failure rate of <1% per year during the
treatment period and for at least 3 months after the final dose of study treatment
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Pregnant or breastfeeding, or intending to become pregnant during the study or within
3 months after the final intravitreal injection of faricimab

- Presence of other ocular diseases that give reasonable suspicion of a disease or
condition that contraindicates the use of faricimab, that might affect interpretation
of the results of the study or that renders the patient at high risk for treatment
complications

- Presence of other diseases, metabolic dysfunction, or clinical laboratory finding
giving reasonable suspicion of a disease or condition that contraindicates the use of
faricimab and that might affect interpretation of the results of the study or that
renders the patient at high risk of treatment complications

- History of a severe allergic reaction or anaphylactic reaction to a biologic agent or
known hypersensitivity to any component of the faricimab injections, study treatment
procedure, dilating drops, or any of the anesthetic and antimicrobial preparations
used by a patient during the study

- Requirement for continuous use of any medications or treatments indicated as
prohibited therapy

Study design
Purpose of the study
Treatment
Allocation to intervention
N/A
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
5/08/2020
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
11/10/2023
Sample size
Target
Accrual to date
Final
1479
Recruitment in Australia
Recruitment state(s)
NSW,VIC,WA
Recruitment hospital [1] 0 0
Strathfield Retina Clinic - Strathfield
Recruitment hospital [2] 0 0
Sydney Eye Hospital - Sydney
Recruitment hospital [3] 0 0
Sydney Retina Clinic and Day Surgery - Sydney
Recruitment hospital [4] 0 0
Sydney West Retina - Westmead
Recruitment hospital [5] 0 0
Centre For Eye Research Australia - East Melbourne
Recruitment hospital [6] 0 0
Retina Specialists Victoria - Rowville
Recruitment hospital [7] 0 0
The Lions Eye Institute - Nedlands
Recruitment postcode(s) [1] 0 0
2135 - Strathfield
Recruitment postcode(s) [2] 0 0
2000 - Sydney
Recruitment postcode(s) [3] 0 0
2145 - Westmead
Recruitment postcode(s) [4] 0 0
3002 - East Melbourne
Recruitment postcode(s) [5] 0 0
3178 - Rowville
Recruitment postcode(s) [6] 0 0
6009 - Nedlands
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Arizona
Country [2] 0 0
United States of America
State/province [2] 0 0
California
Country [3] 0 0
United States of America
State/province [3] 0 0
Colorado
Country [4] 0 0
United States of America
State/province [4] 0 0
Connecticut
Country [5] 0 0
United States of America
State/province [5] 0 0
Florida
Country [6] 0 0
United States of America
State/province [6] 0 0
Georgia
Country [7] 0 0
United States of America
State/province [7] 0 0
Hawaii
Country [8] 0 0
United States of America
State/province [8] 0 0
Illinois
Country [9] 0 0
United States of America
State/province [9] 0 0
Indiana
Country [10] 0 0
United States of America
State/province [10] 0 0
Iowa
Country [11] 0 0
United States of America
State/province [11] 0 0
Kansas
Country [12] 0 0
United States of America
State/province [12] 0 0
Kentucky
Country [13] 0 0
United States of America
State/province [13] 0 0
Maine
Country [14] 0 0
United States of America
State/province [14] 0 0
Maryland
Country [15] 0 0
United States of America
State/province [15] 0 0
Massachusetts
Country [16] 0 0
United States of America
State/province [16] 0 0
Michigan
Country [17] 0 0
United States of America
State/province [17] 0 0
Minnesota
Country [18] 0 0
United States of America
State/province [18] 0 0
Missouri
Country [19] 0 0
United States of America
State/province [19] 0 0
Nevada
Country [20] 0 0
United States of America
State/province [20] 0 0
New Jersey
Country [21] 0 0
United States of America
State/province [21] 0 0
New Mexico
Country [22] 0 0
United States of America
State/province [22] 0 0
New York
Country [23] 0 0
United States of America
State/province [23] 0 0
North Carolina
Country [24] 0 0
United States of America
State/province [24] 0 0
Ohio
Country [25] 0 0
United States of America
State/province [25] 0 0
Oklahoma
Country [26] 0 0
United States of America
State/province [26] 0 0
Oregon
Country [27] 0 0
United States of America
State/province [27] 0 0
Pennsylvania
Country [28] 0 0
United States of America
State/province [28] 0 0
South Carolina
Country [29] 0 0
United States of America
State/province [29] 0 0
Tennessee
Country [30] 0 0
United States of America
State/province [30] 0 0
Texas
Country [31] 0 0
United States of America
State/province [31] 0 0
Utah
Country [32] 0 0
United States of America
State/province [32] 0 0
Vermont
Country [33] 0 0
United States of America
State/province [33] 0 0
Virginia
Country [34] 0 0
United States of America
State/province [34] 0 0
West Virginia
Country [35] 0 0
United States of America
State/province [35] 0 0
Wisconsin
Country [36] 0 0
Argentina
State/province [36] 0 0
Caba
Country [37] 0 0
Argentina
State/province [37] 0 0
Capital Federal
Country [38] 0 0
Argentina
State/province [38] 0 0
Mendoza
Country [39] 0 0
Argentina
State/province [39] 0 0
Rosario
Country [40] 0 0
Argentina
State/province [40] 0 0
San Nicolás
Country [41] 0 0
Austria
State/province [41] 0 0
Graz
Country [42] 0 0
Austria
State/province [42] 0 0
Linz
Country [43] 0 0
Austria
State/province [43] 0 0
Wien
Country [44] 0 0
Brazil
State/province [44] 0 0
GO
Country [45] 0 0
Brazil
State/province [45] 0 0
RS
Country [46] 0 0
Brazil
State/province [46] 0 0
SC
Country [47] 0 0
Brazil
State/province [47] 0 0
SP
Country [48] 0 0
Bulgaria
State/province [48] 0 0
Sofia
Country [49] 0 0
Canada
State/province [49] 0 0
Alberta
Country [50] 0 0
Canada
State/province [50] 0 0
Nova Scotia
Country [51] 0 0
Canada
State/province [51] 0 0
Ontario
Country [52] 0 0
Canada
State/province [52] 0 0
Quebec
Country [53] 0 0
Czechia
State/province [53] 0 0
Hradec Králové
Country [54] 0 0
Czechia
State/province [54] 0 0
Ostrava
Country [55] 0 0
Czechia
State/province [55] 0 0
Prague
Country [56] 0 0
Czechia
State/province [56] 0 0
Sokolov
Country [57] 0 0
Denmark
State/province [57] 0 0
Aalborg
Country [58] 0 0
Denmark
State/province [58] 0 0
Roskilde
Country [59] 0 0
France
State/province [59] 0 0
Bordeaux
Country [60] 0 0
France
State/province [60] 0 0
Creteil
Country [61] 0 0
France
State/province [61] 0 0
Ecully
Country [62] 0 0
France
State/province [62] 0 0
Nantes
Country [63] 0 0
France
State/province [63] 0 0
Paris
Country [64] 0 0
France
State/province [64] 0 0
St Cyr Sur Loire
Country [65] 0 0
Germany
State/province [65] 0 0
Dresden
Country [66] 0 0
Germany
State/province [66] 0 0
Freiburg
Country [67] 0 0
Germany
State/province [67] 0 0
Hannover
Country [68] 0 0
Germany
State/province [68] 0 0
Homburg/Saar
Country [69] 0 0
Germany
State/province [69] 0 0
Magdeburg
Country [70] 0 0
Germany
State/province [70] 0 0
München
Country [71] 0 0
Germany
State/province [71] 0 0
Münster
Country [72] 0 0
Germany
State/province [72] 0 0
Würzburg
Country [73] 0 0
Hong Kong
State/province [73] 0 0
Hong Kong
Country [74] 0 0
Hong Kong
State/province [74] 0 0
Mongkok
Country [75] 0 0
Hungary
State/province [75] 0 0
Budapest
Country [76] 0 0
Hungary
State/province [76] 0 0
Debrecen
Country [77] 0 0
Hungary
State/province [77] 0 0
Pécs
Country [78] 0 0
Hungary
State/province [78] 0 0
Szeged
Country [79] 0 0
Hungary
State/province [79] 0 0
Szombathely
Country [80] 0 0
Hungary
State/province [80] 0 0
Zalaegerszeg
Country [81] 0 0
Israel
State/province [81] 0 0
Haifa
Country [82] 0 0
Israel
State/province [82] 0 0
Jerusalem
Country [83] 0 0
Israel
State/province [83] 0 0
Petach Tikva
Country [84] 0 0
Israel
State/province [84] 0 0
Rehovot
Country [85] 0 0
Israel
State/province [85] 0 0
Tel Aviv
Country [86] 0 0
Italy
State/province [86] 0 0
Lazio
Country [87] 0 0
Italy
State/province [87] 0 0
Liguria
Country [88] 0 0
Italy
State/province [88] 0 0
Lombardia
Country [89] 0 0
Italy
State/province [89] 0 0
Toscana
Country [90] 0 0
Italy
State/province [90] 0 0
Umbria
Country [91] 0 0
Italy
State/province [91] 0 0
Veneto
Country [92] 0 0
Japan
State/province [92] 0 0
Aichi
Country [93] 0 0
Japan
State/province [93] 0 0
Chiba
Country [94] 0 0
Japan
State/province [94] 0 0
Fukuoka
Country [95] 0 0
Japan
State/province [95] 0 0
Hokkaido
Country [96] 0 0
Japan
State/province [96] 0 0
Hyogo
Country [97] 0 0
Japan
State/province [97] 0 0
Ibaraki
Country [98] 0 0
Japan
State/province [98] 0 0
Kumamoto
Country [99] 0 0
Japan
State/province [99] 0 0
Kyoto
Country [100] 0 0
Japan
State/province [100] 0 0
Mie
Country [101] 0 0
Japan
State/province [101] 0 0
Miyazaki
Country [102] 0 0
Japan
State/province [102] 0 0
Nara
Country [103] 0 0
Japan
State/province [103] 0 0
Osaka
Country [104] 0 0
Japan
State/province [104] 0 0
Saitama
Country [105] 0 0
Japan
State/province [105] 0 0
Shiga
Country [106] 0 0
Japan
State/province [106] 0 0
Tokyo
Country [107] 0 0
Korea, Republic of
State/province [107] 0 0
Seongnam-si
Country [108] 0 0
Korea, Republic of
State/province [108] 0 0
Seoul
Country [109] 0 0
Mexico
State/province [109] 0 0
Mexico CITY (federal District)
Country [110] 0 0
Mexico
State/province [110] 0 0
Queretaro
Country [111] 0 0
Peru
State/province [111] 0 0
Lima
Country [112] 0 0
Poland
State/province [112] 0 0
Bielsko-Biala
Country [113] 0 0
Poland
State/province [113] 0 0
Bydgoszcz
Country [114] 0 0
Poland
State/province [114] 0 0
Bytom
Country [115] 0 0
Poland
State/province [115] 0 0
Gda?sk
Country [116] 0 0
Poland
State/province [116] 0 0
Gliwice
Country [117] 0 0
Poland
State/province [117] 0 0
Katowice
Country [118] 0 0
Poland
State/province [118] 0 0
Krakow
Country [119] 0 0
Poland
State/province [119] 0 0
Rybnik
Country [120] 0 0
Poland
State/province [120] 0 0
Rzeszów
Country [121] 0 0
Poland
State/province [121] 0 0
Tarnowskie Góry
Country [122] 0 0
Poland
State/province [122] 0 0
Warszawa
Country [123] 0 0
Poland
State/province [123] 0 0
Wroclaw
Country [124] 0 0
Portugal
State/province [124] 0 0
Braga
Country [125] 0 0
Portugal
State/province [125] 0 0
Coimbra
Country [126] 0 0
Portugal
State/province [126] 0 0
Lisboa
Country [127] 0 0
Russian Federation
State/province [127] 0 0
Baskortostan
Country [128] 0 0
Russian Federation
State/province [128] 0 0
Marij EL
Country [129] 0 0
Russian Federation
State/province [129] 0 0
Moskovskaja Oblast
Country [130] 0 0
Russian Federation
State/province [130] 0 0
Sankt Petersburg
Country [131] 0 0
Russian Federation
State/province [131] 0 0
Tatarstan
Country [132] 0 0
Russian Federation
State/province [132] 0 0
Irkutsk
Country [133] 0 0
Russian Federation
State/province [133] 0 0
Novosibirsk
Country [134] 0 0
Singapore
State/province [134] 0 0
Singapore
Country [135] 0 0
Slovakia
State/province [135] 0 0
Trebišov
Country [136] 0 0
Slovakia
State/province [136] 0 0
Trencin
Country [137] 0 0
Slovakia
State/province [137] 0 0
Zilina
Country [138] 0 0
Spain
State/province [138] 0 0
Asturias
Country [139] 0 0
Spain
State/province [139] 0 0
Barcelona
Country [140] 0 0
Spain
State/province [140] 0 0
LA Coruña
Country [141] 0 0
Spain
State/province [141] 0 0
LAS Palmas
Country [142] 0 0
Spain
State/province [142] 0 0
Madrid
Country [143] 0 0
Spain
State/province [143] 0 0
Navarra
Country [144] 0 0
Spain
State/province [144] 0 0
Valencia
Country [145] 0 0
Spain
State/province [145] 0 0
Albacete
Country [146] 0 0
Spain
State/province [146] 0 0
Alicante
Country [147] 0 0
Spain
State/province [147] 0 0
Valladolid
Country [148] 0 0
Switzerland
State/province [148] 0 0
Binningen
Country [149] 0 0
Taiwan
State/province [149] 0 0
Taipei
Country [150] 0 0
Taiwan
State/province [150] 0 0
Taoyuan
Country [151] 0 0
Taiwan
State/province [151] 0 0
Zhongzheng Dist.
Country [152] 0 0
Thailand
State/province [152] 0 0
Bangkok
Country [153] 0 0
Thailand
State/province [153] 0 0
ChiangMai
Country [154] 0 0
Turkey
State/province [154] 0 0
Ankara
Country [155] 0 0
Turkey
State/province [155] 0 0
Istanbul
Country [156] 0 0
Turkey
State/province [156] 0 0
Izmir
Country [157] 0 0
Turkey
State/province [157] 0 0
Kocaeli
Country [158] 0 0
Turkey
State/province [158] 0 0
Konya
Country [159] 0 0
United Kingdom
State/province [159] 0 0
Belfast
Country [160] 0 0
United Kingdom
State/province [160] 0 0
Bradford
Country [161] 0 0
United Kingdom
State/province [161] 0 0
Canterbury
Country [162] 0 0
United Kingdom
State/province [162] 0 0
Frimley
Country [163] 0 0
United Kingdom
State/province [163] 0 0
Gloucestershire
Country [164] 0 0
United Kingdom
State/province [164] 0 0
Leeds
Country [165] 0 0
United Kingdom
State/province [165] 0 0
Liverpool
Country [166] 0 0
United Kingdom
State/province [166] 0 0
London
Country [167] 0 0
United Kingdom
State/province [167] 0 0
Manchester
Country [168] 0 0
United Kingdom
State/province [168] 0 0
Middx
Country [169] 0 0
United Kingdom
State/province [169] 0 0
Newcastle upon Tyne
Country [170] 0 0
United Kingdom
State/province [170] 0 0
Norfolk
Country [171] 0 0
United Kingdom
State/province [171] 0 0
Southampton
Country [172] 0 0
United Kingdom
State/province [172] 0 0
Sunderland

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Hoffmann-La Roche
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
This is a multicenter long-term extension study designed to evaluate the long-term safety and
tolerability of faricimab administered by intravitreal (IVT) injection at a personalized
treatment interval (PTI) to participants who enrolled in and completed one of the two Phase
III studies, GR40349 (NCT03622580) or GR40398 (NCT03622593), also referred to as the parent
studies.
Trial website
https://clinicaltrials.gov/ct2/show/NCT04432831
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Clinical Trials
Address 0 0
Hoffmann-La Roche
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT04432831